More Company News

Scancell

First patient dosed in SCIB1 Phase II trial
19 Nov 2021Read More

Scancell

Results for the year ended 30 April 2021
29 Oct 2021Read More

Scancell

First subject dosed in South Africa Phase I COVIDITY trial
05 Oct 2021Read More

Scancell

Modi-1 Phase I/II clinical trial application approved by MHRA
26 Aug 2021Read More

Scancell

PharmaJet’s needle-free systems selected for COVIDITY-001 study
17 Aug 2021Read More

Scancell

COVIDITY Phase 1 CTA in South Africa approved
29 Jul 2021Read More

Scancell

Professor Lindy Durrant appointed CEO
28 Jul 2021Read More

Scancell

COVIDITY Phase I trial planned in South Africa and UK
22 Jun 2021Read More

Scancell

Update on SCIB2 clinical development partnership
03 Feb 2021Read More

Scancell

Interim results for six months ended 31 October 2020
29 Jan 2021Read More

1 2 3 4 … 6
Return to Scancell
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).